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Abstract
w3 x w3 x . w3 xWe have investigated the metabolism of 1-O- H octadecyl-sn-glycero-3-phosphocholine H lyso PAF and H myris-
 .tic acid in secondary cultures of aortic smooth muscle cells SMC to characterize the origin of second messengers
 . w3 xgenerated upon stimulation with endothelin-1 ET-1 . When cells were labelled with H lyso PAF, we observed a transfer
 .  . w3 xof the label from phosphatidylcholine PC to phosphatidylethanolamine PE . In contrast, incubation with H myristate
w3 xlabelled mainly PC. Both precursors were incorporated into all PC and PE subclasses. However, H lyso PAF labelled
w3 xmainly alkyl-subclasses while H myristate was associated with diacyl-subclasses. Using these specific labelling proce-
dures, we have shown that ET-1 induced a strong hydrolysis of PE. This hydrolysis was specific for alkyl-PE with a
2q  .maximum after 5 s of stimulation. We have also observed an extracellular Ca -dependent increase in diglyceride DG ,
 .  .phosphatidic acid PA and mainly triglyceride TG concomitant to alkyl-PE hydrolysis. Thus, alkyl-DG generated from
alkyl-PE appears to be a major product in ET-1 stimulation of SMC. These results suggest a new level of complexity in the
signal transduction cascade involving a specificity for phospholipid subclasses.
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Abbreviations: ET-1, Endothelin-1; vSMC, vascular smooth
m uscle cell; PC, phosphatidylcholine; PE, phos -
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DG, diglyceride; TG, triglyceride; EDTA, ethylenediaminete-
traacetic acid; DMEM, Dulbecco’s modified Eagle medium; FCS,
fetal calf serum; ET-1, endothelin-1; alkyl-PC, alkyl-linked-phos-
phatidylcholine; alkyl-PE, alkyl-linked-phosphatidylethanol amine
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1. Introduction
Many cellular processes have been proposed to
participate in atherogenesis, including changes in cell
w x w xproliferation 1 , cell migration 2 and the formation
w xof increased amounts of connective-tissue matrix 3 .
 .Vascular smooth muscle cells vSMC of the media
play an important role in the development of athero-
w xsclerosis 1–4 . They normally acquire a contractile
phenotype in response to vasoactive stimuli. They are
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able to migrate from the media to the intima, and
gain proliferative activity in response to growth fac-
w xtor 5 . It has been shown that some of these pro-
cesses are regulated to some extent by intracellular
2q w x 2qCa 6,7 . Moreover, inhibitors of Ca influx have
been reported to reduce the development of atheroma
w x w xin cholesterol-fed rabbits 8 and monkeys 9 .
Intracellular signalling events which regulate vas-
cular smooth muscle cell proliferation are still poorly
understood. However, it has been shown that the
increase in cell proliferation, observed in vitro after
several cell divisions, may be the result of a dediffer-
w xentiation of the cells 10 . Therefore, a precise charac-
terization of SMC changes during secondary cultures
is necessary to study the mechanisms of agonist-in-
duced signal transduction, specially concerning the
possible modifications in phospholipid composition
and metabolism.
w3 xH Lyso PAF is considered as a specific precursor
of ether-phosphatidylcholine pool. However, it has
been recently shown that PAF could be metabolically
w xconverted into ethanolamine plasmalogens 11 and
that the conversion of alkyl-acyl-glycerophosphocho-
line to alkyl-acyl-glycero phosphoethanolamine al-
.kyl-acyl-GPE in Madin-Darby cells could be due to
the reversion of a choline-phosphotransferase reac-
w xtion 12 . This result raised the question about the
origin of the phospholipids which generate second
messengers in activated cells phosphatidylcholine
 .  ..PC or phosphatidyl-ethanolamine PE . In addition,
w3 xwhen H myristate is used to label phospholipids
and to monitor second messenger production, little is
known about the specificity of the labelling towards
the different phospholipid subclasses. Using various
radio labelled phospholipid precursors, many authors
have shown the activation of different phospholipases
 .and the synthesis of diglyceride DG and phospha-
 .tidic acid PA . However, they have not investigated
the phospholipid subclass precursors involved in these
processes.
 .Endothelin-1 ET-1 , a vasoconstrictor peptide has
been isolated from culture medium of porcine en-
dothelial cells. ET-1 is a 21 amino acid peptide with
w xtwo intramolecular disulphide bonds 13,14 . The
presence of high-affinity ET-1 receptor, belonging to
the family of G-protein-coupled serpentine receptors,
w xhas been reported in cultured rat vSMC 15,16 . ET-1
w xis known to be mitogenic for vSMC 17 and fibrob-
w xlasts 18 maintained in culture, and to be vasocon-
w xtractile for vSMC 19 . These physiological effects
seem to be mediated by phosphoinositide turnover
w x20 . The ET1-specific receptor may be linked to
 .phospholipase C PLC which hydrolyses phos-
 .phatidylinositol-4,5-bisphosphate PIP2 to generate
w xinositol 1,4,5 trisphosphate and DG 21 . Some other
biological effects stimulated by ET-1, such as the
2q w xincrease of intracellular Ca 22 and the biphasic
w xincrease of DG 23,24 , suggest the involvement of
different second messengers. Recent evidences indi-
cate that some receptors coupled to PLC are also
coupled directly or indirectly to phospholipase D
 . w xPLD 25,26 . This enzyme splits PC to form PA, a
w xsource for DG production 27 .
The diversity of phospholipid hydrolysis raises
various questions about the origin of DG and PA
accumulated during the process of cell signalling.
Indeed, both the sequential action of PLCrDG kinase
or PLDrPA phosphatase may produce these second
messengers. The diversity of phospholipid sources
could explain partly the complexity of the responses
generated by the same type of lipid second messen-
gers. Up to now, PIP2 and PC have been regarded as
the predominant precursors of DG and PA. But re-
cently, PLD and PLC have been shown to hydrolyse
w xPE 28,29 , usually the second most abundant phos-
pholipid in mammalian membranes.
Furthermore, in many cell types, both PC and PE
contain significant amounts of ether-linked species.
The functional and metabolic significance of these
ether-linked species is poorly understood. For in-
stance, it has been shown that alkyl-DG was pro-
duced in activated MDCK cells and neutrophils
w x30,31 . It has also been suggested that acyl-DG and
alkyl-DG could be sequentially produced from PI and
w xPC, respectively 32,33 . These studies indicate the
possibilities of cell type and stimulus-specific differ-
ences in the synthesis of acyl-DG and alkyl-DG.
Although acyl-DG is known to be a potent activator
of protein kinase C, alkyl-DG species have been
w xshown to inhibit 34 or to activate protein kinase C
w x35 . Different activities have also been demonstrated
for acyl-DG and alkyl-DG in neutrophils for O8-2
w xrelease 36 . This suggested that alkyl-DG may be
important in the control of signal transduction.
In this paper, we have analysed the specificity of
w3 xPC and PE labelling subclasses when H lyso PAF
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w3 xand H myristate were used as precursors. We have
also established a new transduction pathway in vSMC
stimulated by ET-1, which implies activation of an
extracellular Ca2q-dependent PLC specific for alkyl-
PE.
2. Materials and methods
2.1. Materials
w 3 x1-O- H Octadecyl-sn-glycero-3-phosphocholine
w3 x .  . w3 xH lysoPAF 163 Cirmmol and H myristic acid,
 .54 Cirmmol were purchased from Amersham. Dul-
 .becco’s modified Eagle medium DMEM , fetal calf
 .serum FCS , glutamine and penicillinrstreptomycin
were purchased from Gibco Laboratories.
Endothelin-1, PLC from Bacillus cereus, benzoic
anhydride, dimethyl aminopyridine, dicyclohexyl-
carbodiimide, triacyl and alkyl-TG standards were
 .purchased from Sigma and phosphatidylethanol PEt
was purchased from Avanti Biochemical.
2.2. Cell culture
Smooth muscle cells were obtained from the tho-
w xracic aorta of 6-week-old pig 37 . The aorta was
excised from the pig under sterile conditions and
washed with ice cold DMEM supplemented with 2
mM glutamine and 200 Urml penicillinrstrepto-
mycin. The aorta was opened, and the media was
carefully isolated by removing fat, connective tissue,
endothelium and adventitia. Segments of the media
were cut and sliced into 2 mm2 pieces which were
incubated with DMEM containing 10% FCS at 378C
in a fully humidified atmosphere of 5% CO and2
95% air. The porcine vascular smooth-muscle cells
 .vSMC began migrating from explants after 5 to 10
days. The pieces of tissue were removed after appear-
 .ance of a halo approximately 10 cell deep around
the explant, and cells grown to confluence. For sub-
cultures, cells were dissociated with trypsin-EDTA
 . 30.05% trypsin, 0.02% EDTA and seeded at 4=10
cells per cm2 in tissue culture flasks. Confluence was
obtained a week later. The smooth muscle nature of
the cultures was confirmed by their characteristic
‘hill-and-valley’-like growth pattern. For experi-
ments, cells between the 3rd and the 10th passage
were seeded in 60 mm-diameter dishes, fed every two
days, and used at 70–80% confluence.
2.3. Biochemical analysis
Protein content was determined according to Lowry
w xet al. in the presence of sodium dodecyl sulphate 38 ,
using bovine serum albumin as a standard. Phospho-
w xrus was measured according to Bottcher et al. 39 .¨
2.4. Analysis of phospholipid composition
Cells were grown to confluence, then total lipids
w xwere extracted 40 . They were quantified and sepa-
rated on Merck Silica gel G plates in a two dimen-
sional solvent system first dim ension:
chloroformrmethanolracetic acid, 65r25r10, vrv;
second dimension: chloroformrmethanolrformic
.acid, 65r25r10, vrv . Phospholipids were visu-
alised with iodine vapours, ninhydrine and zinzadze,
and identified by comparison with R values off
commercial standards, co-migrating with the samples.
2.5. Mass determination of phospholipid subclasses
Phospholipids were extracted and the total lipid
extract was divided into three samples one control
.and two samples for subclass determinations as pre-
w xviously described 41 . Sphingomyelins, which are
resistant to the different treatments, were used as
internal standard for phospholipid quantification. Dia-
cyl-phospholipids were specifically degraded in the
two samples using a pancreatic lipase with a high
phospholipase A activity. The control sample and1
one of the lipase-treated samples were separated on
silica gel G using a two dimensional solvent first
dimension: chloroformrmethanolracetic acid,
65r25r10, vrv; second dimension: chloro-
.formrmethanolrformic acid, 65r25r10, vrv . The
phospholipids of the second lipase-treated sample
were first separated in chloroformrmethanolracetic
acidrwater, 65r43r1r3, vrv. Then, alkenyl-phos-
pholipids were degraded using HCl fumes. The re-
maining uncleaved alkyl phospholipids were sepa-
rated using the solvent chloroformrmeth-
anolrammoniarwater, 90r54r5.5r5.5. Spots corre-
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sponding to phospholipid subclasses were scraped,
and the phosphorus content was measured as de-
scribed above. Percentage for each phospholipid sub-
class was calculated from the differences between
 . control total phospholipids , sample 1 total ether-
.  .phospholipids and sample 2 alkyl-phospholipids .
2.6. Determination of optimal radioisotope labelling
w3 x vSMC were labelled with H lyso PAF 1
. w3 x  .mCirml or H myristate 1 mCirml added di-
rectly to DMEM during different periods of time. For
each incubation time, cells were rinsed twice, blocked
with 1 ml of ice-cold methanol, harvested and phos-
pholipids extracted as described below.
2.7. Stimulation of ˝SMC
Prior to stimulation, the labelling medium was
removed at the optimal time and the cells were
 .washed twice with phosphate buffered saline PBS ,
pH 7.4. The cells were incubated with 100 nM ET-1
during the indicated periods. Stimulation was blocked
by addition of 1 ml of ice-cold methanol. The cells
were scraped and lipids extracted according to Bligh
w xand Dyer 40 with addition of the unlabelled carriers
 .PA and DG 5–10 mg .
2.8. Analysis of labelled phospholipid classes
The lipid distribution was assessed on silica gel
plates in a migration system using two different
solvent mixtures performed in the same dimension.
The first migration, stopped in the middle of the
plate, in chloroformrmethanolracetic acid
 .90r10r10, vrv was used to separate phospho-
 .lipids. PC PE PA and PEt After rapid dryness, the
second migration, in hexanerdiethylic etherrformic
 .acid 55r45r1, vrv separated neutral lipids. In this
migration system, PEt are well separated from PA
and monoglycerides. All the spots were visualised in
 .iodine vapour double bonds , identified by co-migra-
tion with commercial standards and analysed for
 .radioactivity level by a scanner Berthold . The spots
were scraped off, mixed to 5 ml scintillation fluid and
measured for radioactivity in a liquid scintillation
counter.
2.9. Detection of PLD acti˝ity
The specific transphosphatidylation property of
w xphospholipase D 42 was used to discriminate the
origin of PA and DG formed after activation. The
w3 x  .cells, labelled with H lyso PAF 1 mCirml for 18
h, were preincubated with or without ethanol 0.5%
.to 2% , before stimulation, for different ranges of
 .time 10 to 30 minutes . Then, they were stimulated
 .with or without ethanol 0.5% to 2% in stimulation
medium. Phosphatidylethanol was separated from PA
and MG by chromatography, using the solvent sys-
tem mentioned above. Its position on the plate was
ascertained in comparison with standard. The radioac-
tivity associated with Pet was found out using a
 .automatic TLC linear analyser Berthold LB 2848 .
Spots corresponding to Pet localization were scraped
off and counted for radioactivity with Picofluor as
scintillation fluid.
2.10. Analysis of the subclasses of PC and PE
Diacyl, alkylacyl and alkenylacyl subclasses were
w xseparated as previously described 43 . Briefly, cells
w3 xwere labelled for 18 h with 1 mCirml of H lyso
w3 xPAF or H myristate, then stimulated or not by 100
nM of ET-1. Lipids were extracted, separated and
identified as described above. Phospholipids PC and
.PE were extracted from the silica using
 .chloroformrmethanol 1r1, vrv . PC and PE ex-
tracts were dried, redissolved in 300 ml of ether and
incubated for 3 h at room temperature in 500 ml of a
 . buffer containing Tris 0.1 M, pH 7.4 , CaCl 102
.  .mM and PLC from B. cereus 20 U . Ether was
evaporated and the DG generated were extracted
from the buffer by 3 rinses in hexane. The DG
coming from phospholipid hydrolysis were benzoy-
lated for 3 h at room temperature with 0.2 M benzoic
anhydride in dichloromethane, 0.4 M dimeth-
ylaminopyridine and 0.5 M dicyclohexyl-carbo-
diimide. The reaction was stopped with hexane and
 .NH OH 1r1 . The supernatant was taken off. Ex-4
traction with hexane was repeated 3 times. The DG
 .subclasses diacyl, alkylacyl, alkenylacyl were sepa-
rated by th in-layer chrom atography in
 .toluenerhexanerether 50r45r4, vrv . Radiola-
belled standards were prepared from diacyl-PC and
ether-PC. Labelled species were detected by a thin-
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 .layer chromatography linear analyser Berthold ,
scraped and quantified in a liquid scintillation anal-
 .yser Packard .
2.11. Analysis of TG subclasses
A system was set up to separate triacyl-TG and
ether-TG. Cells were labelled for 18 h with 1 mCirml
w3 xof H lyso PAF, then stimulated or not by 100 nM
of ET-1. TG subclasses were separated by thin-layer
chromatography in hexaneretherrformic acid
 .80r20r1, vrv and detected with iodine vapours by
comigration with commercial standards. The different
spots were scraped off and quantified.
2.12. Effect of calcium depletion on cell stimulation
 .Prior to stimulation, cells 80% confluence were
washed with PBS, pH 7.4 without calcium and mag-
nesium. Then, they were stimulated in PBS in the
presence or the absence of 1.8 mM CaCl .2
3. Results
3.1. Phospholipid content and phospholipid sub-
classes composition of aortic smooth muscle cells
When smooth muscle cells from pig aorta were
grown in secondary culture, no modification of phos-
pholipid and protein content was observed for the
first 12 passages. Phospholipid to protein ratio corre-
sponded to 184.3"33.7 nmolrmg and the choles-
terol content was 31.6"1.1 nmolr106 cells from
passage 3 to 10. We did not observe any significant
modification of phospholipid composition from pas-
sage 2 to 10.
Analysis of the major phospholipid subclasses in-
 .dicated that diacyl-phosphatidylcholine diacyl-PC
 .represented 76.8%, alkyl-acyl-PC alkyl-PC 16.7%
 .whereas alkenyl-acyl-PC alkenyl-PC corresponded
 .to 6.4% of total PC Table 1 . Diacyl-phosphatidy-
 .lethanolamine diacyl-PE represented 44.6% of total
 .PE while alkyl-acyl-PE alkyl-PE and alkenyl-acyl-
 .PE alkenyl-PE corresponded to 34.5% and 20.8%
of total PE, respectively. Thus ether-phospholipids
were twice as abundant in the PE pool than in the PC
Table 1
Phospholipid composition of aortic smooth muscle cells
Phospholipids %
Sphingomyelin 10.66"0.81
Lyso-phosphatidylcholine 1.46"0.49
Phosphatidylinositol 7.1"0.85
Phosphatidylserine 7.21"0.8
Phosphatidylcholine 49.66"2.8
 .diacyl 38.14"2.81 76.8%
 .alkyl 8.31"0.96 16.7%
 .alkenyl 3.2"0.6 6.4%
Phosphatidylethanolamine 19.53"0.76
 .diacyl 8.72"1.05 44.6%
 .alkyl 6.75"1.35 34.5%
 .alkenyl 4.06"0.73 20.8%
Phosphatidic acid 4.36"0.64
Total 100
Cellular phospholipids from cells at different passages were
extracted, separated and the phosphorus content was determined
as described in Materials and methods. Results represent the
percentages of total lipid phosphorus and are the means"S.E.M.
of eleven separate experiments from passages 3, 6, 8 and 10.
Numbers in parentheses correspond to the percentages of each
subclass relative to the whole class of phosphatidylcholine or
phosphatidylethanolamine.
pool. Compared to other tissues, the alkyl-PE rate
w xwas surprisingly high 44 .
[3 ]3.2. Incorporation and metabolism of H lyso PAF
into PC and PE subclasses of smooth muscle cells
w3 xWhen H lyso PAF was added to subconfluent
cultures of vSMC, a time dependent uptake of the
radioactivity was observed. Maximal incorporation
was obtained at 36 h, representing 50% of the total
 .radioactivity added on the plate data not shown .
w3 xAfter 18 h of incubation with H lyso PAF, 96% of
the intracellular radioactivity were associated with
w3 xlipids. As expected, H lyso PAF was, for a major
 .part, rapidly re-acylated into PC Fig. 1A , represent-
ing up to 70% of total radioactivity after 18 h of
incubation. In contrast, labelled PE represented 10%
of total radioactivity. Phosphatidylinositol and phos-
phatidylserine represented about 1% of total radioac-
 .tivity data not shown . With a longer incubation
 .period 36–72 h , radioactivity associated with PC
did not change significantly, whereas that of PE, PS
and PI still increased. Thus, to avoid contamination
with PI and PS, the following experiments were
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performed after 18 h of incubation at which only PC
and PE were significantly labelled. Base exchange
w xmechanisms were shown in different cell lines 45
and could explain the conversion from PC to PE, but
we cannot exclude other pathways leading to labelled
w3 xPE from H lyso PAF.
w3 xH Lyso PAF has been considered as a specific
precursor of alkyl-phospholipids. Therefore, we la-
w3 xbelled vSMC with H lyso PAF and analysed PC
and PE subclasses after 18 h of incubation. We
observed that about 20% of the total labelled PC
were associated with diacyl-PC, 68% with alkyl-PC
 .and 11% with alkenyl-PC Fig. 1B . PE analysis
indicated that the labelling was recovered into diacyl-
PE, alkyl-PE and alkenyl-PE, 28%, 46% and 25%,
w3 xrespectively. Thus, the label from H alkyl-lysoPAF
w3 xFig. 1. Incorporation of H lyso PAF into lipids and PC or PE
w3 xsubclasses. vSCM were labelled with 1 mCirml of H lyso
PAF. Then, the cells were washed twice and phospholipids were
extracted and analysed as explained in ‘experimental procedures’.
A: Time dependent incorporation into lipids: Data represent the
 .mean"S.E.M. of three separate experiments in triplicate. ^
w3 x  .  .  .  .H lyso-PAF, ‘ PC, v PE, ’ NL neutral lipids . B:
Incorporation into PC and PE subclasses. vSMC were labelled for
18 h and PC and PE subclasses were analysed as explained in
Section 2. Data represent the mean of five separate experiments.
Open bars, diacyl; striped bars, alkyl; black bars, alkenyl.
Fig. 2. Amplification of base substitution between PC and PE.
w3 xvSCM were labelled with 1 mCirml of H lyso-PAF for 48 h.
Then, cells were grown in a non-radioactive medium during
different periods of time. At each incubation time, lipids were
extracted, separated, and the radioactivity was quantified by
liquid scintillation counting. The figure corresponds to one of at
least three experiments realized in triplicate that gave similar
 .  .  .results. ‘ PC, v PE, ’ NL.
was redistributed between every subclass of PC and
PE, but at different rates.
As shown in Fig. 2, we visualised the interconver-
sion between PC and PE using a 48-h prelabelling
followed by incubations in non-radioactive medium.
In the prelabelled cells, 49% of total radioactivity
was present in PC, and 33% in PE. After 24 h of
incubation in the unlabelled medium, 50% of total
radioactivity was associated with PE. The conversion
was maximal after 48 h of incubation. Neutral lipids
labelling remained stable.
In order to label the PE pool specifically, we
w3 xincubated vSMC with H alkyl-lyso PE, prepared in
our laboratory. We observed a rapid interconversion
w3 xfrom PE to PC. After 18 h of incubation with H al-
kyl-lyso PE, 41.4%"4.2 of total radioactivity was
incorporated into PE and 21.2%"2.8 into PC pool
 .data not shown . This indicate that the base substitu-
tion was not a mechanism specific for the PC sub-
strate.
[ 3 ]3.3. Incorporation of H myristic acid into PC and
PE subclasses of ˝SMC
In order to label differently the hydrophobic moi-
w3 xety of phospholipids, we have analysed H myristate
( )C. Comminges et al.rBiochimica et Biophysica Acta 1355 1997 69–80 75
incorporation. After 18 h of incubation with
w3 xH myristate, about 20% of total radioactivity were
incorporated into phospholipids of vSMC. However
the labelling was mainly associated with PC, repre-
senting 83% of total radioactivity incorporated into
 .the cells Fig. 3A . PE and neutral lipids displayed
5.6% and 3% of radioactivity, respectively. PI and PS
represented 2.6% and 2.8% of the total labelling data
. w3 xnot shown . Unlike H lyso PAF, at longer time of
w3 xincubation H myristate remained mainly associated
with PC.
w3 xH Myristate has been often used for its specific
labelling of diacyl-phospholipids. We analysed PC
 .and PE subclasses after 18 h of incubation Fig. 3B
and found that 89% of the total radioactivity in PC
were recovered in diacyl-PC, 9.3% in alkyl-PC and
w3 xFig. 3. Incorporation of H myristic acid into lipids and PC or
w3 xPE subclasses. vSCM were labelled with 1 mCirml of H myr-
istic acid during different periods of time. Then phospholipids
were extracted and analysed as explained in ‘experimental proce-
dures’. A: Incorporation into lipids.The data represent the mean
 . w3 x"S.E.M. of 2 experiments realized in triplicate. I H myri-
 .  .  .state, ‘ PC, v PE, ’ NL. B: Time dependent incorpora-
tion into PC and PE subclasses. vSMC were labelled for 18 h. PC
and PE were extracted, separated and were analysed as described
in Section 2. Data represented the mean of three separate experi-
ments. Open bars, diacyl; striped bars, alkyl; black bars, alkenyl.
w3 xFig. 4. Effect of endothelin-1 on vSMC labelled with H lyso
w3 xPAF. vSCM, prelabelled with 1 mCirml of H lyso-PAF for 18
h, were stimulated with 100 nM endothelin-1 from 5 to 30 s in
DMEM. Each point represents the mean"S.E.M. of five experi-
ments in triplicate. Note the different scales of % of total
  .radioactivity between panels A and B 16% full scale and panel
 .  .  .  .  .C 4% full scale . A: ‘ PC. B: v PE, I TG. C: ^ DG,
 . ) )) )))B PA. P -0.05; P -0.02; P -0.01.
0.95% in alkenyl-PC. In contrast, diacyl-PE, alkyl-PE
and alkenyl-PE represented respectively 53%, 14.5%
and 32.3% of the total PE radioactivity. Thus
w3 xH myristate acid could be used as a more specific
label for diacyl subclasses.
3.4. Effect of endothelin-1 on ˝SMC labelled with
[3 ]H lyso PAF
w3 xCells were prelabelled for 18 h with H lyso PAF,
then stimulated with 100 nM of ET-1. We observed
that ET-1 strongly activated the hydrolysis of PE
 . Fig. 4B with a maximum 5 s after stimulation 30 to
.40% hydrolysis P-0.01 . In contrast, labelled PC
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 .Fig. 4A were not significantly hydrolysed. PE hy-
drolysis was concomitant to the production of DG in
 .the first 10 s Fig. 4C . The time-course for PA
accumulation was delayed when compared to DG,
 .but was sustained for at least 20 s Fig. 4C . We also
 .observed a rapid synthesis of triglycerides TG which
 .  .paralleled PE hydrolysis P-0.01 Fig. 4B .
PA generation led us to investigate the presence of
a PLD activity stimulated by ET-1. We incubated the
 .cells in the presence of 0.5% vrv to 2% ethanol
value described to be in the range of cell stimulation
.levels by ethanol in order to detect the synthesis of
 . w xphosphatidylethanol PEt 46,47 . However, PEt
could not be detected and PA level remained constant
under our conditions, ruling out the involvement of
PLD able to hydrolyse ether-linked-phospholipids in
vSMC. This suggested that ET-1 could stimulate a
PLC acting on PE.
3.5. Determination of the subclasses of PC, PE and
TG in stimulated cells
Because PE hydrolysis was activated upon ET-1
stimulation, we analysed which subclass was actually
involved in the process. We have shown that PC
subclass distribution did not change significantly af-
 .ter ET-1 stimulation Fig. 5 . In contrast, alkyl-PE
decreased from 46.3% "9.8 to 22.8% "2.5 P-
.0.05 of total PE, representing about 50% hydrolysis
of this phospholipid. Thus, ET-1 was able to activate
specifically alkyl-PE hydrolysis.
To analyse the origin of TG produced after 5 s of
stimulation, we determined the relative proportions of
triacyl- and ether-TG on ET-1 stimulated cells. We
observed that ether-TG increased after stimulation
 .Fig. 5 , indicating that these TG could come from a
rapid reacylation of DG generated by ET-1.
3.6. Effect of extracellular calcium on ET-1 stimu-
lated ˝SMC
To examine the effect of Ca2q influx on ET-1
stimulated PE hydrolysis, cells were treated with the
2q .agonist, with or without Ca 1.8 mM in the incuba-
tion medium. We measured phospholipid hydrolysis
and second messengers generation after 10 s of stim-
 .ulation Fig. 6 . We observed that alkyl-PE hydroly-
sis and synthesis of DG, PA and TG were strictly
dependent on the presence of Ca2q in the medium,
suggesting that the phospholipase activated by ET-1
was dependent on extracellular Ca2q.
w3 xFig. 5. Determination of the subclasses of hydrolysed PC and PE and newly synthetized TG. Cells were labelled with H lyso-PAF for
18 h and stimulated or not with 100 nM of ET-1 for 5 s. Phospholipids were extracted, separated and digested with PLC. The obtained
DG were extracted, benzoylated and separated as described in Section 2. Results for PC and PE represent the mean of five experiments.
)P-0.05. Subclasses of TG were separated by TLC. Results represent the mean of three experiments. Open bars, control; dotted bars,
ET-1.
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Fig. 6. Effect of extracellular calcium on endothelin-1 stimulation
w3 xof vSMC. vSMC prelabelled with H lyso-PAF were stimulated
in PBS containing or not 1.8 mM of calcium. Each point repre-
sents the mean"S.E.M. of three determinations. I with Ca2q,
B without Ca2q.
3.7. Effect of endothelin-1 on ˝SMC labelled with
[3 ]H myristic acid
In order to examine the possible specificity of the
ET-1 stimulation for alkyl-phospholipids, we used
w3 xH myristate labelling, this one being incorporated
 .mainly into diacyl-phospholipids Fig. 3B . ET-1 ac-
 .tivated a minor hydrolysis of labelled PE 6% in the
 .first 5 s after stimulation Fig. 7 . No hydrolysis of
 . w3 xPC was observed data not shown . Since H myri-
state labelled mainly diacyl-PC, this result agreed
w3 xFig. 7. Effect of endothelin-1 on vSMC labelled with H myris-
w3 xtic acid. vSCM, prelabelled with 1 mCirml of H myristic acid
for 18 h, were stimulated with 100 nM endothelin-1 from 5 to 30
s. Phospholipids were extracted and analysed as described in
Section 2. Each point represents the mean"S.E.M. of two exper-
 .iments in triplicate. v PE.
with the specificity of ET-1 stimulation towards
alkyl-PE.
4. Discussion
w3 xH Lyso PAF has been mostly used as a specific
precursor for PC in order to investigate the genera-
tion of second messengers specifically deriving from
w xPC in signal transduction pathways 48,49 . For in-
stance, in neutrophils, 75 min of incubation with
w3 xH lyso PAF allowed 50% of the label to be taken
up by the cells, and about 80% was converted into
w3 x w xH phosphatidylcholine 50 . Interestingly, we ob-
w3 xserved that in vSMC H lyso PAF could be highly
incorporated into PC but also into PE. This intercon-
version between PC and PE pools was time depen-
dent and could be observed as soon as 1 h after
w3 xaddition of H lyso PAF. It could result from a base
w xexchange reaction 45,51 leading to phospholipid
remodelling in cell membranes. However, because
we observed a similar distribution of labelled DG and
 .PE subclasses data not shown , we cannot exclude
that one part of PE comes from the action of ethanol-
amine phosphotransferase. Furthermore, in contrast to
w3 xother cell types, we have shown that H lyso PAF
labelling was not exclusive for alkyl-PC or -PE in
w xvSMC 51,52 . Indeed, after 18 h of incubation, 20%
of total labelled PC were present in diacyl-PC and
12% in alkenyl-PC. Similarly, 25% of total radioac-
tivity were incorporated into alkenyl-PE and 28%
into diacyl-PE. These results raised the question of
w3 xthe incorporation of the H alkyl moiety into the
three phospholipid subclasses of PC and PE. If 1-O-
alkyl bonds are resistant to the action of phospholi-
pases A1 and B, specific enzymes can cleave the
ether bond and yield to long-chain aldehydes and
w xglycerol 53 . The long-chain aldehydes can be oxi-
dised into the corresponding fatty acids, which are
able to reacylate lyso-phospholipids into diacyl-phos-
w xpholipids 54 . In addition, the conversion of 1-O-al-
kyl-phospholipids to 1-O-alkenyl-phospholipids oc-
curs through a desaturase reaction introducing a dou-
ble bond between C-1 and C-2 of the alkyl moiety
w x55,56 . It has been shown that alkyl-acyl-GPE could
be substrate for the desaturase, leading to the forma-
w xtion of alkenyl-acyl-GPE 57 . So far, this mechanism
w xappeared to be slow 58 , but our data indicate that it
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could be rapid in vSMC. Lysophospholipase D acting
specifically on alkyl, but not on acyl-lysophospho-
w xlipids has also been observed 59 . This lysophospho-
lipase D could participate in a sequence of reactions
involving acyltransferases as well as choline and
ethanolamine-phosphotransferases, participating to
the interconversion of choline plasmalogens and
w xethanolamine plasmalogens 60 .
w3 x w3 xIn contrast to H alkyl-lyso PAF, H myristate
was mainly incorporated into diacyl subclass of PC.
These differential labelling procedures were useful to
characterize the origin and the type of second mes-
sengers produced upon activation of vSMC with ET-1.
In addition, whereas numerous results have been
reported for PC, only a few data indicate the involve-
ment of PE as a precursor of second messengers
w x w14 x61,62 . These reports are based on C ethanol-
amine labelling of PE, but no experimental data have
been reported on PE labelled in the glycerol back-
bone or the alkyl-chain. Furthermore, the hydrolysed
w14 xC ethanolamine molecules are rapidly reincorpo-
w xrated into phospholipids 28 , so it is quite difficult,
using this approach, to precisely measure the amount
of ethanolamine or phosphoethanolamine generated
w3 xupon activation. Thus, we used H alkyl-lyso-PAF
w3 xor H myristate to follow phospholipid hydrolysis
and to detect the labelled second messengers poten-
tially generated from PC or PE after stimulation.
When the cells were stimulated with ET-1, signal
w3 xtransduction pathways involving H alkyl-PE hydro-
lysis were activated and we observed a transient
generation of DG, which was maximal after 10 s of
stimulation. PA synthesis was delayed when com-
pared to DG and because no PLD was stimulated in
the first 30 s, we concluded that PA production might
depend on the activation of DG-kinase. We also
observed a synthesis of TG, corresponding to the
kinetics of PE hydrolysis. Since a direct exchange
between the phosphoethanolamine group and a fatty
acid is unlikely, TG synthesis might come from a
rapid acylation of generated DG via acyl-transferase
reaction. Because N-acyl-PE are separated from TG
in our solvent system, we can rule out the possibility
of an acylation of PE on ethanolamine to explain the
decrease in PE. TG synthesis might thus represent a
rapid intracellular pathway to eliminate fatty acids.
However, we cannot exclude a role for newly synthe-
sised TG in the transduction cascade.
w3 xInterestingly, while H lyso-PAF labelling indi-
cated a specific hydrolysis of PE, this was not ob-
w3 xserved upon H myristate labelling. The preferential
w3 x subclass labelling between H yso-PAF mainly
. w3 x  .alkyl-PE and H myristate mainly diacyl-PE could
explain the difference observed in Figs. 4 and 7.
Moreover, if we consider that labelled alkyl-PE de-
w3 xrived from H myristate labelling represented only
14% of total PE, the 6% of the hydrolysed PE might
correspond to a 43% of hydrolysis of alkyl-subclass
which was in agreement with the results obtained
w3 xfrom H lyso-PAF labelling. So, we concluded that
ET-1 induced the hydrolysis of a specific pool of PE,
alkyl-PE, in aortic SMC. Different signalling path-
ways were shown in vSMC. For instance, ET-1 was
able to stimulate a phosphatidylinositol specific PLC
w x w x18,63 and to induce a DG accumulation 23 . Other
reports have shown that ET-1 stimulates PLD in A10
w xand rat aorta vSMC 64,65 . We suggest herein that
ET-1 can stimulate a PLC acting on alkyl-PE. These
different hydrolytic activities could be in relationship
with specific cellular responses to the same agonist.
w xAs it has been suggested 32,66 , alkyl-DG appears
to be an important product generated after stimulation
of some cell types. It has been suggested that acyl-DG
and alkyl-DG species could have different bioactivi-
w xties 34–36 . According to our results, alkyl-DG gen-
erated from PE may have a specific role in the
control of agonist-induced signal transduction.
The study of the mechanisms concerning this puta-
tive PE-specific PLC is still in progress in our labora-
tory. Furthermore, the strict specificity of the phos-
pholipase C for an alkyl-phospholipid, and the syn-
thesis of alkyl-second messengers led us to suggest a
new level of complexity in the regulation of sig-
nalling, since the specificity of a given phospholipase
for a phospholipid substrate could determine the
specificity of an agonist-dependent signal.
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